Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

Paul J. Hampel; Sameer A. Parikh; Timothy G. Call; Mithun V. Shah; N. Nora Bennani; Aref Al-Kali; Kari G. Rabe; Yucai Wang; Eli Muchtar; Jose F. Leis; Saad S. Kenderian; Amber B. Koehler; Susan M. Schwager; Susan L. Slager; Neil E. Kay; Curtis A. Hanson; Daniel L. Van Dyke; Min Shi; Wei Ding

doi:10.1038/s41408-021-00443-1

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun V. Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kenderian, Amber B. Koehler, Susan M. Schwager, Susan L. Slager, Neil E. Kay, Curtis A. Hanson, Daniel L. Van Dyke, Min Shi, Wei Ding

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Article number	47
Journal	Blood cancer journal
Volume	11
Issue number	3
DOIs	https://doi.org/10.1038/s41408-021-00443-1
State	Published - Mar 2021

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-021-00443-1

Cite this

Hampel, P. J., Parikh, S. A., Call, T. G., Shah, M. V., Bennani, N. N., Al-Kali, A., Rabe, K. G., Wang, Y., Muchtar, E., Leis, J. F., Kenderian, S. S., Koehler, A. B., Schwager, S. M., Slager, S. L., Kay, N. E., Hanson, C. A., Van Dyke, D. L., Shi, M., & Ding, W. (2021). Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia. Blood cancer journal, 11(3), Article 47. https://doi.org/10.1038/s41408-021-00443-1

Hampel, PJ, Parikh, SA, Call, TG, Shah, MV, Bennani, NN, Al-Kali, A, Rabe, KG, Wang, Y, Muchtar, E, Leis, JF, Kenderian, SS, Koehler, AB, Schwager, SM, Slager, SL , Kay, NE, Hanson, CA, Van Dyke, DL, Shi, M & Ding, W 2021, 'Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia', Blood cancer journal, vol. 11, no. 3, 47. https://doi.org/10.1038/s41408-021-00443-1

@article{96c5d9484c15416ca35f0257487ef17a,

title = "Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia",

author = "Hampel, {Paul J.} and Parikh, {Sameer A.} and Call, {Timothy G.} and Shah, {Mithun V.} and Bennani, {N. Nora} and Aref Al-Kali and Rabe, {Kari G.} and Yucai Wang and Eli Muchtar and Leis, {Jose F.} and Kenderian, {Saad S.} and Koehler, {Amber B.} and Schwager, {Susan M.} and Slager, {Susan L.} and Kay, {Neil E.} and Hanson, {Curtis A.} and {Van Dyke}, {Daniel L.} and Min Shi and Wei Ding",

year = "2021",

month = mar,

doi = "10.1038/s41408-021-00443-1",

language = "English (US)",

volume = "11",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

AU - Hampel, Paul J.

AU - Parikh, Sameer A.

AU - Call, Timothy G.

AU - Shah, Mithun V.

AU - Bennani, N. Nora

AU - Al-Kali, Aref

AU - Rabe, Kari G.

AU - Wang, Yucai

AU - Muchtar, Eli

AU - Leis, Jose F.

AU - Kenderian, Saad S.

AU - Koehler, Amber B.

AU - Schwager, Susan M.

AU - Slager, Susan L.

AU - Kay, Neil E.

AU - Hanson, Curtis A.

AU - Van Dyke, Daniel L.

AU - Shi, Min

AU - Ding, Wei

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85101904804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101904804&partnerID=8YFLogxK

U2 - 10.1038/s41408-021-00443-1

DO - 10.1038/s41408-021-00443-1

M3 - Letter

C2 - 33654067

AN - SCOPUS:85101904804

SN - 2044-5385

VL - 11

JO - Blood cancer journal

JF - Blood cancer journal

IS - 3

M1 - 47

ER -

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this